Deltex Historical Income Statement

DEMG Stock   0.08  0.00  0.00%   
Historical analysis of Deltex Medical income statement accounts such as Total Revenue of 1.7 M or Gross Profit of 1.1 M can show how well Deltex Medical Group performed in making a profits. Evaluating Deltex Medical income statement over time to spot trends is a great complementary tool to traditional technical analysis and can indicate the direction of Deltex Medical's future profits or losses.
 
Dot-com Bubble
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
Financial Statement Analysis is much more than just reviewing and examining Deltex Medical Group latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Deltex Medical Group is a good buy for the upcoming year.
  
Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Deltex Medical Group. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

About Deltex Income Statement Analysis

Deltex Medical Group Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to Deltex Medical shareholders. The income statement also shows Deltex investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).

Deltex Medical Income Statement Chart

At this time, Deltex Medical's Depreciation And Amortization is comparatively stable compared to the past year. Research Development is likely to gain to about 268.4 K in 2024, whereas Total Revenue is likely to drop slightly above 1.7 M in 2024.

Total Revenue

Total revenue comprises all receipts Deltex Medical Group generated from the sale of its products or services. The total amount of income generated by the sale of goods or services related to the company's primary operations.

Other Operating Expenses

Other Operating Expenses is the expense which generally does not depend on sales or production quantities of Deltex Medical Group. It is also known as Deltex Medical overhead expenses. Typically these expenses include marketing, rent and utilities, office, leases, and other overhead cost. Expenses incurred from non-core business activities, including administrative and general expenses, but excluding costs directly related to production.

Cost Of Revenue

Cost of Revenue is found on Deltex Medical Group income statement and represents the costs associated with goods and services Deltex Medical provides. Indirect cost, such as salaries, is not included. In other words, cost of revenue is the total cost incurred to obtain a sale. It is more than the traditional cost of goods sold, since it includes specific selling and marketing activities.
Most accounts from Deltex Medical's income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into Deltex Medical Group current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Deltex Medical Group. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.
At this time, Deltex Medical's Depreciation And Amortization is comparatively stable compared to the past year. Research Development is likely to gain to about 268.4 K in 2024, whereas Total Revenue is likely to drop slightly above 1.7 M in 2024.
 2021 2022 2023 2024 (projected)
Interest Expense173K199K230K116.1K
Depreciation And Amortization114K128K133K231.8K

Deltex Medical income statement Correlations

0.030.650.670.6-0.14-0.340.14-0.210.580.6-0.23-0.23-0.21-0.04-0.030.51-0.27-0.37-0.360.19-0.110.53
0.03-0.27-0.23-0.410.690.6-0.540.64-0.36-0.420.66-0.60.67-0.55-0.8-0.570.65-0.550.71-0.550.83-0.65
0.65-0.270.990.96-0.4-0.550.62-0.470.960.96-0.440.08-0.42-0.110.070.88-0.560.12-0.710.62-0.580.72
0.67-0.230.990.94-0.33-0.480.63-0.410.930.93-0.370.07-0.35-0.150.020.85-0.50.14-0.680.59-0.530.69
0.6-0.410.960.94-0.63-0.750.63-0.690.981.0-0.660.23-0.640.070.260.95-0.760.14-0.80.68-0.710.79
-0.140.69-0.4-0.33-0.630.97-0.40.98-0.55-0.650.98-0.610.98-0.61-0.75-0.750.95-0.230.74-0.590.8-0.69
-0.340.6-0.55-0.48-0.750.97-0.430.99-0.68-0.760.98-0.470.98-0.48-0.63-0.820.98-0.130.75-0.530.78-0.74
0.14-0.540.620.630.63-0.4-0.43-0.430.570.64-0.410.42-0.40.110.320.67-0.450.6-0.640.48-0.650.57
-0.210.64-0.47-0.41-0.690.980.99-0.43-0.62-0.710.99-0.520.99-0.5-0.65-0.770.98-0.180.72-0.510.79-0.69
0.58-0.360.960.930.98-0.55-0.680.57-0.620.97-0.590.1-0.57-0.010.180.9-0.70.07-0.760.65-0.670.74
0.6-0.420.960.931.0-0.65-0.760.64-0.710.97-0.680.26-0.650.090.280.96-0.770.16-0.810.69-0.710.8
-0.230.66-0.44-0.37-0.660.980.98-0.410.99-0.59-0.68-0.511.0-0.59-0.73-0.760.97-0.180.75-0.530.79-0.73
-0.23-0.60.080.070.23-0.61-0.470.42-0.520.10.26-0.51-0.520.540.690.45-0.460.6-0.540.61-0.660.42
-0.210.67-0.42-0.35-0.640.980.98-0.40.99-0.57-0.651.0-0.52-0.62-0.75-0.750.96-0.190.75-0.530.79-0.72
-0.04-0.55-0.11-0.150.07-0.61-0.480.11-0.5-0.010.09-0.590.54-0.620.90.31-0.440.22-0.530.43-0.470.53
-0.03-0.80.070.020.26-0.75-0.630.32-0.650.180.28-0.730.69-0.750.90.49-0.610.42-0.70.59-0.710.66
0.51-0.570.880.850.95-0.75-0.820.67-0.770.90.96-0.760.45-0.750.310.49-0.830.32-0.920.78-0.840.9
-0.270.65-0.56-0.5-0.760.950.98-0.450.98-0.7-0.770.97-0.460.96-0.44-0.61-0.83-0.210.78-0.550.83-0.76
-0.37-0.550.120.140.14-0.23-0.130.6-0.180.070.16-0.180.6-0.190.220.420.32-0.21-0.470.37-0.560.39
-0.360.71-0.71-0.68-0.80.740.75-0.640.72-0.76-0.810.75-0.540.75-0.53-0.7-0.920.78-0.47-0.840.92-0.96
0.19-0.550.620.590.68-0.59-0.530.48-0.510.650.69-0.530.61-0.530.430.590.78-0.550.37-0.84-0.750.73
-0.110.83-0.58-0.53-0.710.80.78-0.650.79-0.67-0.710.79-0.660.79-0.47-0.71-0.840.83-0.560.92-0.75-0.81
0.53-0.650.720.690.79-0.69-0.740.57-0.690.740.8-0.730.42-0.720.530.660.9-0.760.39-0.960.73-0.81
Click cells to compare fundamentals

Deltex Medical Account Relationship Matchups

Deltex Medical income statement Accounts

201920202021202220232024 (projected)
Depreciation And Amortization233K143K114K128K133K231.8K
Interest Expense176K172K173K199K230K116.1K
Total Revenue4.3M2.4M2.3M2.5M1.8M1.7M
Gross Profit3.1M1.5M1.5M1.7M1.1M1.1M
Other Operating Expenses4.1M3.4M3.4M3.5M2.8M2.7M
Operating Income133K(1.0M)(1.2M)(1.0M)(1.1M)(1.1M)
Ebit133K(674K)(862K)(1.0M)(1.1M)(1.2M)
Research Development353K203K167K191K217K268.4K
Ebitda366K(531K)(748K)(890K)(1.0M)(1.1M)
Cost Of Revenue1.1M851K776K735K651K618.5K
Total Operating Expenses3.0M2.6M2.6M2.8M2.2M2.1M
Income Before Tax(210K)(846K)(1.0M)(1.2M)(1.4M)(1.4M)
Total Other Income Expense Net(395K)(343K)(172K)(230.0K)(313K)(297.4K)
Net Income(161K)(798K)(967K)(1.1M)(1.3M)(1.3M)
Income Tax Expense(51K)(61K)(69K)(72K)(83K)(78.9K)
Selling General Administrative1.5M1.5M1.6M1.6M1.1M1.7M
Selling And Marketing Expenses1.2M964K957K1.0M685K650.8K
Net Income From Continuing Ops(159K)(785K)(966K)(1.1M)(1.3M)(1.3M)
Net Income Applicable To Common Shares(159K)(785K)(966K)(1.1M)(1.3M)(1.4M)
Minority Interest(147K)(141K)(139K)(126K)(113.4K)(119.1K)
Tax Provision(74K)(51K)(9K)(12K)(1K)0.0
Net Interest Income(176K)(172K)(173K)(199K)(230K)(241.5K)
Interest Income135K177K173K171K196.7K144.5K
Reconciled Depreciation233K143K114K128K133K186.3K

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Deltex Stock Analysis

When running Deltex Medical's price analysis, check to measure Deltex Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Deltex Medical is operating at the current time. Most of Deltex Medical's value examination focuses on studying past and present price action to predict the probability of Deltex Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Deltex Medical's price. Additionally, you may evaluate how the addition of Deltex Medical to your portfolios can decrease your overall portfolio volatility.